Polar Asset Management Partners Inc. Has $15.48 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Polar Asset Management Partners Inc. lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 26.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,658 shares of the medical equipment provider's stock after selling 10,900 shares during the period. Polar Asset Management Partners Inc.'s holdings in Intuitive Surgical were worth $15,480,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at $25,000. Hurley Capital LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $28,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth $26,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at about $26,000. Finally, BankPlus Trust Department bought a new position in Intuitive Surgical in the 4th quarter worth approximately $28,000. Institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now directly owns 7,162 shares of the company's stock, valued at $4,060,424.28. This represents a 2.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. This represents a 60.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 32,700 shares of company stock valued at $16,865,621 in the last three months. Insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Up 0.6%

NASDAQ:ISRG traded up $3.32 during mid-day trading on Friday, reaching $563.60. 1,422,176 shares of the stock were exchanged, compared to its average volume of 1,644,552. Intuitive Surgical, Inc. has a 1-year low of $395.60 and a 1-year high of $616.00. The firm has a market capitalization of $202.00 billion, a PE ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70. The business has a fifty day moving average price of $505.22 and a 200 day moving average price of $536.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the business posted $1.50 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Truist Financial decreased their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Finally, UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.